NextFin

ARKK ETF Sees Major Portfolio Shifts: TSLA Up $63.77M, TEM Gains $53.13M

Summarized by NextFin AI
  • Tesla Inc (TSLA) saw a significant increase in position value by approximately $63.77 million, indicating a bullish augmentation.
  • CRISPR Therapeutics AG (CRSP) position decreased modestly by about $10.50 million, reflecting a partial reduction.
  • Tempus AI Inc-A (TEM) experienced a substantial buy with an increase of roughly $53.13 million.
  • Robinhood Markets Inc-A (HOOD) increased by $39.46 million, suggesting confidence in its growth.

Overview

ARKK ETF experienced notable trading activity on 2026-04-17, with several flagship holdings showing significant shifts in portfolio weight and value.

Detailed Summary

  • Tesla Inc (TSLA) saw a significant increase in position value by approximately $63.77 million, indicating a bullish augmentation.
  • CRISPR Therapeutics AG (CRSP) position decreased modestly by about $10.50 million, reflecting a partial reduction.
  • Tempus AI Inc-A (TEM) experienced a substantial buy with an increase of roughly $53.13 million.
  • Robinhood Markets Inc-A (HOOD) increased by $39.46 million, suggesting confidence in its growth.
  • Shopify Inc-A (SHOP) also saw an increase of $31.14 million.
  • Coinbase Global Inc-A (COIN) enjoyed a sizeable purchase of $24.62 million.
  • Advanced Micro Devices Inc (AMD) position was slightly increased by about $10.91 million.
  • Roku Inc-A (ROKU) rose by $13.76 million.
  • Beam Therapeutics Inc (BEAM) position grew by around $9.72 million.
  • CRCL decreased by approximately $7.68 million.

Analysis and Interpretation

The buying spree mainly in technology and biotech sectors aligns with ARKK's innovation-focused investment strategy. Tesla's significant buy represents confidence in electric vehicle market expansion. Increases in Tempus AI, Robinhood, Coinbase, and Beam Therapeutics underscore ARKK's focus on AI, fintech, and gene editing innovation. Reduction in CRSP and CRCL might reflect tactical trimming or profit-taking. Overall, the portfolio tilt towards growth and disruptive innovation remains evident in these trades.

Position Changes Table

Ticker Company Name Direction Shares Traded (Proxy) Estimated Trade Value ($) % of Portfolio Change
TSLA Tesla Inc Buy 63,766,220 $63,766,219.50 +0.3710%
CRSP CRISPR Therapeutics AG Buy 10,501,983 $10,501,983.30 -0.2401%
TEM Tempus AI Inc-A Buy 53,134,622 $53,134,622.27 +0.4840%
HOOD Robinhood Markets Inc-A Buy 39,463,612 $39,463,611.77 +0.3029%
SHOP Shopify Inc-A Buy 31,136,526 $31,136,526.18 +0.1982%
CRCL Buy 7,681,200 $7,681,200.03 -0.1528%
COIN Coinbase Global Inc-A Buy 24,619,890 $24,619,889.76 +0.1096%
AMD Advanced Micro Devices Inc Buy 10,910,790 $10,910,789.85 -0.0993%
ROKU Roku Inc-A Buy 13,761,137 $13,761,137.25 -0.0353%
BEAM Beam Therapeutics Inc Buy 9,724,745 $9,724,744.70 -0.0848%

This report provides a comprehensive overview of ARKK's daily position changes for April 17, 2026. If you need further analysis or additional information, feel free to ask!

Explore more exclusive insights at nextfin.ai.

Insights

What is ARKK's overall investment strategy?

How does ARKK's trading activity reflect current market trends?

What factors are driving the growth of companies like Tesla and Tempus AI?

What recent changes have occurred in ARKK's portfolio on April 17, 2026?

How has user feedback responded to ARKK's investment choices?

What are the implications of ARKK's increased investment in biotech sectors?

What challenges does ARKK face in maintaining its innovation focus?

How does ARKK's performance compare to other innovation ETFs?

What controversies exist around ARKK's investment strategies?

How might ARKK's shifts in portfolio affect its long-term growth?

What historical trends can be observed in ARKK's trading activities?

What is the significance of the reductions in positions like CRISPR Therapeutics?

What role does innovation play in ARKK's investment decisions?

What future developments can we expect in the ARK investment strategy?

How do ARKK's recent trades align with broader industry trends?

What potential risks are associated with investing in disruptive innovation?

Which sectors are currently favored by ARKK's investment approach?

How do recent market dynamics influence ARKK's position changes?

What lessons can be learned from ARKK's trading decisions on April 17, 2026?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App